A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
The Trump administration is greatly expanding the number of illegal immigrants in the country who are considered a priority for deportation.
The feature on the Facebook-owned app is strikingly similar to similar "story" elements on Instagram and Snapchat.
Merseyside Police are hunting convicted murderer Shaun Walmsley after two armed men helped him escape custody while on a hospital visit.